{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Parrish AG"],"funding":["NCI NIH HHS"],"pagination":["vdae148"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11459063"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["6(1)"],"pubmed_abstract":["<h4>Background</h4>Meningiomas are the most common primary central nervous system tumors in adults. Although generally benign, a subset is of higher grade and ultimately fatal. Around half of all meningiomas harbor inactivating mutations in NF2, leading to deregulation of oncogenic YAP1 activity. While benign NF2 mutant meningiomas exhibit few genetic events in addition to NF2 inactivation, aggressive high-grade NF2 mutant meningiomas frequently harbor a highly aberrant genome. It is unclear if NF2 mutant meningiomas of different grades are equally reliant on YAP activity.<h4>Methods</h4>We analyzed bulk and single-cell RNA-Seq data from a large cohort of human meningiomas for the expression of YAP1 target genes and Hippo effectors as well as in vitro cell line experiments.<h4>Results</h4>"],"journal":["Neuro-oncology advances"],"pubmed_title":["Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4."],"pmcid":["PMC11459063"],"funding_grant_id":["R35 CA253119"],"pubmed_authors":["Schmid S","Sahm F","Rudoy D","Parrish AG","Holland EC","Szulzewsky F","Thirimanne HN","Arora S","Sievers P"],"additional_accession":[]},"is_claimable":false,"name":"Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4.","description":"<h4>Background</h4>Meningiomas are the most common primary central nervous system tumors in adults. Although generally benign, a subset is of higher grade and ultimately fatal. Around half of all meningiomas harbor inactivating mutations in NF2, leading to deregulation of oncogenic YAP1 activity. While benign NF2 mutant meningiomas exhibit few genetic events in addition to NF2 inactivation, aggressive high-grade NF2 mutant meningiomas frequently harbor a highly aberrant genome. It is unclear if NF2 mutant meningiomas of different grades are equally reliant on YAP activity.<h4>Methods</h4>We analyzed bulk and single-cell RNA-Seq data from a large cohort of human meningiomas for the expression of YAP1 target genes and Hippo effectors as well as in vitro cell line experiments.<h4>Results</h4>","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan-Dec","modification":"2026-07-14T20:35:33.539Z","creation":"2025-04-04T01:46:47.365Z"},"accession":"S-EPMC11459063","cross_references":{"pubmed":["39380691"],"doi":["10.1093/noajnl/vdae148"]}}